Trial of radioactive implants offers improved prostate cancer survival
by Press Association from on (#7VZ3)
Treatment using permanently implanted radioactive 'seeds' doubles rates of five-year tumour-free survival compared with conventional high-dose radiotherapy
A prostate cancer treatment using permanently implanted radioactive "seeds" doubles rates of five-year tumour-free survival compared with conventional high-dose radiotherapy, a study has found.
Low-dose-rate prostate brachytherapy (LDR-PB) involves the insertion of tiny radioactive implants into the prostate gland.
Continue reading...